Insurance Coverage for Dayvigo (Lemborexant)
Insurance coverage for Dayvigo varies significantly by plan type, with most commercial and Medicare Part D plans covering it but typically placing it on higher cost-sharing tiers (tier 3 or higher) that require substantial out-of-pocket costs, prior authorizations, or step therapy requirements.
Coverage by Insurance Type
Medicare Part D
Medicare Part D plans generally cover Dayvigo, but with important limitations 1:
- Tier placement: Most plans place Dayvigo on tier ≥3, which means higher copayments since it lacks a generic equivalent
- Prior authorization: Required by approximately 24% of Medicare plans for similar newer sleep medications 1
- Out-of-pocket costs: Can be substantial even with coverage, as coinsurance is based on the list price, not negotiated net prices 2
- Coverage phases: You'll face different cost-sharing depending on which phase of Medicare Part D coverage you're in (deductible, initial coverage, coverage gap/"donut hole," catastrophic coverage) 2
Commercial/Private Insurance
Private insurance plans typically cover Dayvigo but with restrictions:
- Formulary placement: Usually on non-preferred tiers requiring higher copayments
- Prior authorization: Often required to demonstrate medical necessity
- Step therapy: May require trying and failing older, generic sleep medications first
- Negotiated rebates: While PBMs negotiate rebates with manufacturers, these savings rarely translate to lower patient out-of-pocket costs 2
Medicaid
Medicaid coverage varies by state 2:
- If Dayvigo is on your state's preferred drug list, copayments are typically nominal ($1-$5)
- If not on the preferred list, your prescriber can submit a prior authorization request demonstrating medical necessity
- Coverage decisions and restrictions vary significantly between states
Key Coverage Barriers
Prior authorization and step therapy are the primary obstacles you'll likely encounter 1. Insurance companies use these tools to:
- Limit coverage of newer, more expensive medications
- Require documentation of failed trials with older alternatives
- Control costs through administrative barriers
Important Considerations
Cost-Sharing Reality
Even with insurance coverage, your actual out-of-pocket costs may be substantial because 2:
- Coinsurance percentages are calculated on the drug's list price, not the discounted price your insurance negotiates
- Deductibles must be met before coverage begins
- High-tier placement means higher copayments or coinsurance rates
Checking Your Specific Coverage
You must verify coverage with your specific plan because:
- Formularies vary between plans, even within the same insurance company
- Prior authorization requirements differ
- Cost-sharing structures are plan-specific
Contact your insurance company's pharmacy benefits department or check your plan's online formulary to determine:
- Whether Dayvigo is covered
- Which tier it's placed on
- Whether prior authorization is required
- What your specific out-of-pocket cost will be
- Whether step therapy is mandated
Manufacturer Assistance
If insurance coverage is denied or costs are prohibitive, contact Eisai Inc. (the manufacturer) about patient assistance programs that may help reduce out-of-pocket costs 3.
Clinical Context
Dayvigo is FDA-approved and clinically effective for insomnia 4, 5, but insurance coverage does not equal affordability. The complexity of the pharmaceutical supply chain and insurance benefit design means that even covered medications can impose significant financial burden 2, 1.